Get the latest Science News and Discoveries

Novel peptide formulation shows promise of restoring cognitive decline in schizophrenia - EurekAlert


Schizophrenia is a serious mental health disorder linked to the imbalance of chemical neurotransmitters that affect cognitive capabilities. Current therapies against schizophrenia have numerous limitations, largely due to the selective permeability of blood-brain barrier, which necessitates the development of novel strategies. Advancing research, scientists from Japan Advanced Institute of Science and Technology have now developed targeted drug delivery systems using peptide-based nanoparticles, that improved cognitive decline in animal models of schizophrenia.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Schizophrenia

Schizophrenia

Photo of EurekAlert

EurekAlert

Photo of cognitive decline

cognitive decline

Related news:

News photo

Spring frost no more: Genetic discovery delays peach bloom, safeguards crops - EurekAlert

News photo

Creating sustainable cooling in southeast Asia using ground source heat pump systems - EurekAlert

News photo

Research uncovers pyrethrum's genetic secrets, boosting eco-friendly pest control and sustainable farming practices - EurekAlert